News
Combining ubiquitin specific peptidase 8 genotype with tumor size could help predict the risk for recurrence in patients with Cushing’s disease who have undergone successful pituitary surgery, say researchers.
Regardless of treatment modality, effective control of hypercortisolism in patients with bilateral adrenal tumors is key to achieving favorable cardiovascular outcomes, suggests a data analysis of the ENSAT trial.
Cushing’s Hub is proud to support Rare Disease Day 2026—an annual rare moment that unites patients, families, clinicians, and advocates to bring rare diseases into the spotlight.
People with cyclic Cushing’s syndrome have a high risk for spontaneous adrenal insufficiency, delayed diagnosis, and inappropriate surgeries, suggests an observational study in The Lancet Diabetes and Endocrinology.
The Editorial Board is delighted to congratulate Dr Stefano Testa of the Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy, on being selected as this year’s winner of the prestigious Cushing’s Hub Competition.